85 related articles for article (PubMed ID: 14648614)
1. TGSA-Flex: Extending the capabilities of the Topo-Geometrical Superposition Algorithm to handle flexible molecules.
Gironés X; Carbó-Dorca R
J Comput Chem; 2004 Jan; 25(2):153-9. PubMed ID: 14648614
[TBL] [Abstract][Full Text] [Related]
2. Molecular tongs containing amino acid mimetic fragments: new inhibitors of wild-type and mutated HIV-1 protease dimerization.
Bannwarth L; Kessler A; Pèthe S; Collinet B; Merabet N; Boggetto N; Sicsic S; Reboud-Ravaux M; Ongeri S
J Med Chem; 2006 Jul; 49(15):4657-64. PubMed ID: 16854071
[TBL] [Abstract][Full Text] [Related]
3. Quantum similarity superposition algorithm (QSSA): a consistent scheme for molecular alignment and molecular similarity based on quantum chemistry.
Bultinck P; Kuppens T; Gironés X; Carbó-Dorca R
J Chem Inf Comput Sci; 2003; 43(4):1143-50. PubMed ID: 12870905
[TBL] [Abstract][Full Text] [Related]
4. Graph-based molecular alignment (GMA).
Marialke J; Körner R; Tietze S; Apostolakis J
J Chem Inf Model; 2007; 47(2):591-601. PubMed ID: 17381175
[TBL] [Abstract][Full Text] [Related]
5. 3D-QSAR studies on chromone derivatives as HIV-1 protease inhibitors: application of molecular field analysis.
Nunthanavanit P; Anthony NG; Johnston BF; Mackay SP; Ungwitayatorn J
Arch Pharm (Weinheim); 2008 Jun; 341(6):357-64. PubMed ID: 18442018
[TBL] [Abstract][Full Text] [Related]
6. Computational design of novel fullerene analogues as potential HIV-1 PR inhibitors: Analysis of the binding interactions between fullerene inhibitors and HIV-1 PR residues using 3D QSAR, molecular docking and molecular dynamics simulations.
Durdagi S; Mavromoustakos T; Chronakis N; Papadopoulos MG
Bioorg Med Chem; 2008 Dec; 16(23):9957-74. PubMed ID: 18996019
[TBL] [Abstract][Full Text] [Related]
7. Optimization and computational evaluation of a series of potential active site inhibitors of the V82F/I84V drug-resistant mutant of HIV-1 protease: an application of the relaxed complex method of structure-based drug design.
Perryman AL; Lin JH; Andrew McCammon J
Chem Biol Drug Des; 2006 May; 67(5):336-45. PubMed ID: 16784458
[TBL] [Abstract][Full Text] [Related]
8. Comparative studies on inhibitors of HIV protease: a target for drug design.
Jayaraman S; Shah K
In Silico Biol; 2008; 8(5-6):427-47. PubMed ID: 19374129
[TBL] [Abstract][Full Text] [Related]
9. In silico drug screening approach for the design of magic bullets: a successful example with anti-HIV fullerene derivatized amino acids.
Durdagi S; Supuran CT; Strom TA; Doostdar N; Kumar MK; Barron AR; Mavromoustakos T; Papadopoulos MG
J Chem Inf Model; 2009 May; 49(5):1139-43. PubMed ID: 19371030
[TBL] [Abstract][Full Text] [Related]
10. Drug design: new inhibitors for HIV-1 protease based on Nelfinavir as lead.
Perez MA; Fernandes PA; Ramos MJ
J Mol Graph Model; 2007 Oct; 26(3):634-42. PubMed ID: 17459746
[TBL] [Abstract][Full Text] [Related]
11. Design of peptidomimetic inhibitors of aspartic protease of HIV-1 containing -Phe Psi Pro- core and displaying favourable ADME-related properties.
Frecer V; Berti F; Benedetti F; Miertus S
J Mol Graph Model; 2008 Oct; 27(3):376-87. PubMed ID: 18678515
[TBL] [Abstract][Full Text] [Related]
12. BRUTUS: optimization of a grid-based similarity function for rigid-body molecular superposition. 1. Alignment and virtual screening applications.
Tervo AJ; Rönkkö T; Nyrönen TH; Poso A
J Med Chem; 2005 Jun; 48(12):4076-86. PubMed ID: 15943481
[TBL] [Abstract][Full Text] [Related]
13. Flexible alignment of small molecules using the penalty method.
Shin W; Hyun SA; Chae CH; Chon JK
J Chem Inf Model; 2009 Aug; 49(8):1879-88. PubMed ID: 19645428
[TBL] [Abstract][Full Text] [Related]
14. A self-organizing algorithm for molecular alignment and pharmacophore development.
Bandyopadhyay D; Agrafiotis DK
J Comput Chem; 2008 Apr; 29(6):965-82. PubMed ID: 17999384
[TBL] [Abstract][Full Text] [Related]
15. Incorporating protein flexibility in structure-based drug discovery: using HIV-1 protease as a test case.
Meagher KL; Carlson HA
J Am Chem Soc; 2004 Oct; 126(41):13276-81. PubMed ID: 15479081
[TBL] [Abstract][Full Text] [Related]
16. The signature molecular descriptor. 2. Enumerating molecules from their extended valence sequences.
Faulon JL; Churchwell CJ; Visco DP
J Chem Inf Comput Sci; 2003; 43(3):721-34. PubMed ID: 12767130
[TBL] [Abstract][Full Text] [Related]
17. Enhancing specificity and sensitivity of pharmacophore-based virtual screening by incorporating chemical and shape features--a case study of HIV protease inhibitors.
Pandit D; So SS; Sun H
J Chem Inf Model; 2006; 46(3):1236-44. PubMed ID: 16711743
[TBL] [Abstract][Full Text] [Related]
18. Receptor flexibility in de novo ligand design and docking.
Alberts IL; Todorov NP; Dean PM
J Med Chem; 2005 Oct; 48(21):6585-96. PubMed ID: 16220975
[TBL] [Abstract][Full Text] [Related]
19. [Screening of new HIV inhibitors based on the database of traditional Chinese medicine].
Gao WN; Li Y; Zhang R; Gao H; Xu WR; Li AX; Du QS; Zhang X; Wei DQ
Yao Xue Xue Bao; 2006 Mar; 41(3):241-6. PubMed ID: 16758996
[TBL] [Abstract][Full Text] [Related]
20. Combination of non-natural D-amino acid derivatives and allophenylnorstatine-dimethylthioproline scaffold in HIV protease inhibitors have high efficacy in mutant HIV.
Nakatani S; Hidaka K; Ami E; Nakahara K; Sato A; Nguyen JT; Hamada Y; Hori Y; Ohnishi N; Nagai A; Kimura T; Hayashi Y; Kiso Y
J Med Chem; 2008 May; 51(10):2992-3004. PubMed ID: 18426195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
